WINSTON-SALEM, N.C. & PHILADELPHIA--(BUSINESS WIRE)--Clinical Ink, the pioneering provider of eSource solutions for clinical trials, announced today that the SureSource platform has been selected for multiple Ebola clinical studies. SureSource is unique in that the critical study data and site documents are available for real-time analysis and remote review – limiting the number of healthcare workers that will come in contact with the virus while speeding up the analysis process. “The Ebola out